Dominant KCNA2 mutation causes episodic ataxia and pharmacoresponsive epilepsy
Mark A Corbett, Susannah T Bellows, Melody Li, Renee Carroll, Silvana Micallef, Gemma L Carvill, Candace T Myers, Katherine B Howell, Snezana Maljevic, Holger Lerche, Elena V Gazina, Heather C Mefford, Melanie Bahlo, Samuel F Berkovic, Steven Petrou, Ingrid E Scheffer, Jozef Gecz
NEUROLOGY | LIPPINCOTT WILLIAMS & WILKINS | Published : 2016
Related Projects (3)
Awarded by NHMRC program
Awarded by NHMRC Research Fellowships
Awarded by NHMRC Practitioner Fellowship
This project was supported by NHMRC program grants 628952 (S.T.B., S.F.B., J.G., I.E.S., S.P.) and 1054618 (M.B.), NHMRC Research Fellowships 1041920 (J.G.) and 1002098 (M.B.), NHMRC Practitioner Fellowship 1104831 (I.E.S.), WCH foundation MS McLeod research fellowship (M.A.C.), Victorian Government's Operational Infrastructure Support Program, and Australian Government NHMRC IRIISS.